1,800+ associates. 86 countries. One Regulatory Affairs. At Novartis your voice, experience, and quality mindset can truly make a difference in Regulatory Affairs (RA). Novartis has a unique and promising portfolio with 70 projects as potential NMEs in development, 65 projects in Phase 3 or already undergoing registration, and 100 Phase 1/2 projects. Novartis Institutes for Biomedical Research (NIBR) is world renowned for its groundbreaking science in drug development including cell and gene therapies. RA plays a critical role planning first-in-human strategies through development decision point and long-term project strategy. We work closely with NIBR scientists on innovative medicines for diseases with a high unmet medical need. Read on to learn about the role available in Regulatory